- Home
- CCBG vs OCS Comparison
CCBG vs OCS Comparison
Compare CCBG & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCBG | OCS |
|---|---|---|
| Founded | 1895 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 828.1M | 732.4M |
| IPO Year | 1994 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CCBG | OCS |
|---|---|---|
| Price | $51.05 | $8.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $51.83 | $37.01 |
| AVG Volume (30 Days) | 68.0K | ★ 305.3K |
| Earning Date | 10-20-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | ★ 15.38 | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.18 | N/A |
| Revenue Next Year | $3.29 | $365.20 |
| P/E Ratio | $55.17 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.55 | $7.11 |
| 52 Week High | $53.60 | $34.48 |
Technical Indicators
Market Signals| Indicator | CCBG | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 61.01 | 45.43 |
| Support Level | $47.63 | $7.11 |
| Resistance Level | $51.04 | $10.84 |
| Average True Range (ATR) | 0.95 | 0.45 |
| MACD | 0.30 | 0.18 |
| Stochastic Oscillator | 82.13 | 80.28 |
Price Performance
Historical ComparisonAbout CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services, among others, through its banking offices in Florida, Georgia, and Alabama.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.